Overall, DNMT3A and TET2 loci were successfully amplified in 97.7% and 98.1% of cells, respectively, resulting in clonal assignment for 93.0% of CH cells (Figure S3C). This evidence concerns the gene TET2 and cyclic hematopoiesis.